Clinical Trial Update: Efficacy of iOWH032 in Dehydrating Cholera [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating iOWH032 for dehydration due to cholera/secretory diarrhea has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera
• Secretory Diarrhea

Drugs mentioned

• iOWH032 (iOWH032)

Snippet

Sponsor: PATH | Conditions: Secretory Diarrhea | Phase 2 | Status: WITHDRAWN